{"id":117021,"date":"2026-06-15T10:16:03","date_gmt":"2026-06-15T04:46:03","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=117021"},"modified":"2026-06-15T10:16:05","modified_gmt":"2026-06-15T04:46:05","slug":"lasa-supergenerics-share-price-target-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/","title":{"rendered":"Lasa Supergenerics Share Price Target 2026 Analyst Forecast Bull and Bear Case"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>The Lasa Supergenerics share price target 2026 is Rs 8.56, implying approximately 20 percent upside from the current market price of Rs 7.13 (NSE: LASA). With Q4 FY26 results released in 2026 and Pharmaceutical Intermediates and Veterinary APIs sector tailwinds accelerating, the path to Rs 8.56 is supported by FY27 earnings recovery.<\/em><\/p>\n<p>The <strong><a href=\"https:\/\/univest.in\/user\/stocks\/lasa\/lasa-supergenerics-ltd-share-price-today\">Lasa Supergenerics<\/a> share price target 2026<\/strong> is Rs 8.56, based on analyst estimates and the FY27 earnings recovery thesis for Lasa Supergenerics (NSE: LASA). Q4 FY26 results released in 2026 are the immediate re-rating trigger. This article covers the complete <strong>Lasa Supergenerics share price target<\/strong> analysis including sector tailwinds, peer context, key risks, and bull and bear case scenarios.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#Lasa_Supergenerics_Share_Price_Target_2026_Key_Takeaways\" title=\"Lasa Supergenerics Share Price Target 2026: Key Takeaways\">Lasa Supergenerics Share Price Target 2026: Key Takeaways<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#Lasa_Supergenerics_Company_Overview\" title=\"Lasa Supergenerics Company Overview\">Lasa Supergenerics Company Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#Why_Is_the_Lasa_Supergenerics_Share_Price_Target_Set_at_Rs_856_for_2026\" title=\"Why Is the Lasa Supergenerics Share Price Target Set at Rs 8.56 for 2026\">Why Is the Lasa Supergenerics Share Price Target Set at Rs 8.56 for 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#FY27_Earnings_Delivery_and_Revenue_Acceleration\" title=\"FY27 Earnings Delivery and Revenue Acceleration\">FY27 Earnings Delivery and Revenue Acceleration<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#Structural_Sector_Tailwinds_in_Pharmaceutical_Intermediates_and_Veterinary_APIs\" title=\"Structural Sector Tailwinds in Pharmaceutical Intermediates and Veterinary APIs\">Structural Sector Tailwinds in Pharmaceutical Intermediates and Veterinary APIs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#RBI_Rate_Cut_Cycle_and_Lower_Cost_of_Capital\" title=\"RBI Rate Cut Cycle and Lower Cost of Capital\">RBI Rate Cut Cycle and Lower Cost of Capital<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#Union_Budget_2026-27_Policy_Support\" title=\"Union Budget 2026-27 Policy Support\">Union Budget 2026-27 Policy Support<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#Improving_FII_Flows_and_Market_Normalisation_in_2026\" title=\"Improving FII Flows and Market Normalisation in 2026\">Improving FII Flows and Market Normalisation in 2026<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#Lasa_Supergenerics_Share_Price_Targets_Short_Term_12_Month_and_Long_Term\" title=\"Lasa Supergenerics Share Price Targets: Short Term, 12 Month, and Long Term\">Lasa Supergenerics Share Price Targets: Short Term, 12 Month, and Long Term<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#Short_Term_Lasa_Supergenerics_Share_Price_Target\" title=\"Short Term Lasa Supergenerics Share Price Target\">Short Term Lasa Supergenerics Share Price Target<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#12-Month_Lasa_Supergenerics_Share_Price_Target_2026\" title=\"12-Month Lasa Supergenerics Share Price Target 2026\">12-Month Lasa Supergenerics Share Price Target 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#Long_Term_Lasa_Supergenerics_Share_Price_Target_FY27_to_FY28\" title=\"Long Term Lasa Supergenerics Share Price Target: FY27 to FY28\">Long Term Lasa Supergenerics Share Price Target: FY27 to FY28<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#Bull_Case_and_Bear_Case_for_the_Lasa_Supergenerics_Share_Price_Target\" title=\"Bull Case and Bear Case for the Lasa Supergenerics Share Price Target\">Bull Case and Bear Case for the Lasa Supergenerics Share Price Target<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#Bull_Case_Lasa_Supergenerics_Share_Price_Target_Rs_103\" title=\"Bull Case Lasa Supergenerics Share Price Target: Rs 10.3\">Bull Case Lasa Supergenerics Share Price Target: Rs 10.3<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#Bear_Case_Lasa_Supergenerics_Share_Price_Target_Rs_570\" title=\"Bear Case Lasa Supergenerics Share Price Target: Rs 5.70\">Bear Case Lasa Supergenerics Share Price Target: Rs 5.70<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#Key_Risks_to_the_Lasa_Supergenerics_Share_Price_Target_2026\" title=\"Key Risks to the Lasa Supergenerics Share Price Target 2026\">Key Risks to the Lasa Supergenerics Share Price Target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#Global_Macro_and_Tariff_Risk\" title=\"Global Macro and Tariff Risk\">Global Macro and Tariff Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#Valuation_and_Earnings_Miss_Risk\" title=\"Valuation and Earnings Miss Risk\">Valuation and Earnings Miss Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#Competitive_Pressure_in_Pharmaceutical_Intermediates_and_Veterinary_APIs\" title=\"Competitive Pressure in Pharmaceutical Intermediates and Veterinary APIs\">Competitive Pressure in Pharmaceutical Intermediates and Veterinary APIs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#FII_Selling_and_Liquidity_Risk\" title=\"FII Selling and Liquidity Risk\">FII Selling and Liquidity Risk<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#How_to_Invest_in_Lasa_Supergenerics\" title=\"How to Invest in Lasa Supergenerics\">How to Invest in Lasa Supergenerics<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#FAQs_on_Lasa_Supergenerics_Share_Price_Target_2026\" title=\"FAQs on Lasa Supergenerics Share Price Target 2026\">FAQs on Lasa Supergenerics Share Price Target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#What_is_the_Lasa_Supergenerics_share_price_target_for_2026\" title=\"What is the Lasa Supergenerics share price target for 2026?\">What is the Lasa Supergenerics share price target for 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#What_is_the_Lasa_Supergenerics_share_price_target_for_2025\" title=\"What is the Lasa Supergenerics share price target for 2025?\">What is the Lasa Supergenerics share price target for 2025?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#Is_Lasa_Supergenerics_a_good_buy_at_Rs_713\" title=\"Is Lasa Supergenerics a good buy at Rs 7.13?\">Is Lasa Supergenerics a good buy at Rs 7.13?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#What_is_the_52_week_high_and_low_of_Lasa_Supergenerics\" title=\"What is the 52 week high and low of Lasa Supergenerics?\">What is the 52 week high and low of Lasa Supergenerics?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#What_are_the_key_risks_to_the_Lasa_Supergenerics_share_price_target\" title=\"What are the key risks to the Lasa Supergenerics share price target?\">What are the key risks to the Lasa Supergenerics share price target?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#What_are_the_catalysts_for_the_Lasa_Supergenerics_share_price_target\" title=\"What are the catalysts for the Lasa Supergenerics share price target?\">What are the catalysts for the Lasa Supergenerics share price target?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#How_does_Lasa_Supergenerics_compare_to_its_peers\" title=\"How does Lasa Supergenerics compare to its peers?\">How does Lasa Supergenerics compare to its peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/univest.in\/blogs-2\/lasa-supergenerics-share-price-target-2026\/#What_is_the_Lasa_Supergenerics_share_price_target_for_2027\" title=\"What is the Lasa Supergenerics share price target for 2027?\">What is the Lasa Supergenerics share price target for 2027?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Lasa_Supergenerics_Share_Price_Target_2026_Key_Takeaways\"><\/span><strong>Lasa Supergenerics Share Price Target 2026: Key Takeaways<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Lasa Supergenerics share price target 2026:<\/strong> Rs 8.56 (20% upside from CMP Rs 7.13)<\/li>\n<li><strong>Bull case:<\/strong> Rs 10.3 | <strong>Bear case:<\/strong> Rs 5.70<\/li>\n<li><strong>Ticker:<\/strong> LASA | <strong>Sector:<\/strong> Pharmaceutical Intermediates and Veterinary APIs | <strong>MCap:<\/strong> Rs 71 crore<\/li>\n<li><strong>52W range:<\/strong> Rs 5.00 to Rs 14 | <strong>PE:<\/strong> sector-average<\/li>\n<li><strong>Key catalyst:<\/strong> Q4 FY26 results released in 2026 confirming FY27 earnings trajectory<\/li>\n<li><strong>Key risk:<\/strong> FY27 earnings miss or sustained FII outflows from Indian equities<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Lasa_Supergenerics_Company_Overview\"><\/span><strong>Lasa Supergenerics Company Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Lasa Supergenerics (NSE: LASA) is a Tarapur-based pharmaceutical intermediates and veterinary API company manufacturing specialty chemicals for animal health and pharma applications. At CMP Rs 7.13 against a 52 week range of Rs 5.00 to Rs 14, the stock trades at a discount to its 52 week high. Market capitalisation is Rs 71 crore with trailing PE of sector-average. Compared to peers in pharma intermediates sector, Lasa Supergenerics is positioned as a potential re-rating candidate toward the <strong>Lasa Supergenerics share price target<\/strong> of Rs 8.56.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Parameter<\/th>\n<th>Value<\/th>\n<\/tr>\n<tr>\n<td>NSE Ticker<\/td>\n<td>LASA<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Pharmaceutical Intermediates and Veterinary APIs<\/td>\n<\/tr>\n<tr>\n<td>CMP (2026)<\/td>\n<td>Rs 7.13<\/td>\n<\/tr>\n<tr>\n<td>52 Week High<\/td>\n<td>Rs 14<\/td>\n<\/tr>\n<tr>\n<td>52 Week Low<\/td>\n<td>Rs 5.00<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 71 crore<\/td>\n<\/tr>\n<tr>\n<td>Trailing PE<\/td>\n<td>sector-average<\/td>\n<\/tr>\n<tr>\n<td>12-Month Analyst Target<\/td>\n<td>Rs 8.56<\/td>\n<\/tr>\n<tr>\n<td>Bull Case Target<\/td>\n<td>Rs 10.3<\/td>\n<\/tr>\n<tr>\n<td>Bear Case Target<\/td>\n<td>Rs 5.70<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<div style=\"background: #E8EAFF; border-radius: 14px; padding: 28px 32px 24px 32px; margin: 24px 0; font-family: -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,sans-serif; cursor: pointer; max-width: 100%; box-sizing: border-box;\">\n<p style=\"font-size: 20px; font-weight: bold; color: #0a0a23; margin: 0 0 12px 0; line-height: 1.3;\">3 Stocks Building Serious Momentum Right Now<\/p>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 14px 0; line-height: 1.6;\">When <strong style=\"color: #0a0a23;\">Univest analysts<\/strong> identify high-conviction stock opportunities, <em>investors pay attention.<\/em><\/p>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 14px 0; line-height: 1.6;\">Our research team has now shortlisted the <strong style=\"color: #0a0a23;\">Top Stocks to Buy<\/strong> based on current market momentum, sector trends &amp; growth potential for 2026.<\/p>\n<ul style=\"margin: 0 0 16px 20px; padding: 0; color: #3a3a5c; font-size: 15px; line-height: 1.8;\">\n<li>Discover stocks investors are actively accumulating<\/li>\n<li>High-conviction opportunities backed by research<\/li>\n<li>Designed for the next phase of market growth<\/li>\n<\/ul>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 20px 0;\">Unlock the latest <a style=\"color: #3b7fff; font-weight: bold; text-decoration: none;\" href=\"https:\/\/univest.in\/user\/payment?planType=ALL_PRO%20PLANS\" target=\"_blank\" rel=\"noopener\">Top Stock Picks<\/a> now on Univest<\/p>\n<p><a style=\"display: inline-block; background: #3B7FFF; color: #fff; font-size: 15px; font-weight: 600; padding: 13px 28px; border-radius: 50px; letter-spacing: 0.2px; text-decoration: none;\" href=\"https:\/\/univest.in\/user\/payment?planType=ALL_PRO%20PLANS\" target=\"_blank\" rel=\"noopener\">See the Stocks \u2192<\/a><\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Why_Is_the_Lasa_Supergenerics_Share_Price_Target_Set_at_Rs_856_for_2026\"><\/span><strong>Why Is the Lasa Supergenerics Share Price Target Set at Rs 8.56 for 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"FY27_Earnings_Delivery_and_Revenue_Acceleration\"><\/span><strong>FY27 Earnings Delivery and Revenue Acceleration<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>Lasa Supergenerics share price target 2026<\/strong> of Rs 8.56 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Q4 FY26 results released in 2026 confirming the earnings recovery trajectory are the most direct catalyst for re-rating from CMP Rs 7.13 toward Rs 8.56.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Structural_Sector_Tailwinds_in_Pharmaceutical_Intermediates_and_Veterinary_APIs\"><\/span><strong>Structural Sector Tailwinds in Pharmaceutical Intermediates and Veterinary APIs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Pharmaceutical Intermediates and Veterinary APIs sector is expanding on the back of India&#8217;s domestic demand growth, PLI scheme support, and rising investment. Lasa Supergenerics&#8217;s market position among peers in pharma intermediates sector creates a structural growth runway supporting the <strong>Lasa Supergenerics share price target<\/strong> of Rs 8.56 and bull case of Rs 10.3.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"RBI_Rate_Cut_Cycle_and_Lower_Cost_of_Capital\"><\/span><strong>RBI Rate Cut Cycle and Lower Cost of Capital<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s RBI rate cut cycle in 2026 reduces Lasa Supergenerics&#8217;s borrowing costs and stimulates end market demand. Lower interest costs improve the EPS trajectory, directly supporting the <strong>Lasa Supergenerics share price target<\/strong> of Rs 8.56.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Union_Budget_2026-27_Policy_Support\"><\/span><strong>Union Budget 2026-27 Policy Support<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Budget 2026-27&#8217;s Rs 11.21 lakh crore infrastructure capex and PLI scheme continuity create a positive policy backdrop for Lasa Supergenerics&#8217;s Pharmaceutical Intermediates and Veterinary APIs operations, improving the probability of achieving the <strong>Lasa Supergenerics share price target<\/strong> of Rs 8.56.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Improving_FII_Flows_and_Market_Normalisation_in_2026\"><\/span><strong>Improving FII Flows and Market Normalisation in 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>As global macro conditions normalise through 2026, FII flows into quality Indian equities are recovering. At sector-average PE, Lasa Supergenerics is positioned as a beneficiary of institutional reallocation toward the <strong>Lasa Supergenerics share price target<\/strong> of Rs 8.56.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Lasa_Supergenerics_Share_Price_Targets_Short_Term_12_Month_and_Long_Term\"><\/span><strong>Lasa Supergenerics Share Price Targets: Short Term, 12 Month, and Long Term<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Short_Term_Lasa_Supergenerics_Share_Price_Target\"><\/span><strong>Short Term Lasa Supergenerics Share Price Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The near-term <strong>Lasa Supergenerics share price target<\/strong> is anchored to support near the 52 week low of Rs 5.00. A confirmed Q4 FY26 earnings recovery in 2026 is the trigger for an initial 10 to 15 percent re-rating toward Rs 8.56.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"12-Month_Lasa_Supergenerics_Share_Price_Target_2026\"><\/span><strong>12-Month Lasa Supergenerics Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 12-month <strong>Lasa Supergenerics share price target 2026<\/strong> is Rs 8.56, implying approximately 20 percent upside from CMP Rs 7.13. This base case assumes in-line FY27 earnings delivery and partial FII flow normalisation. Track live on NSE ticker LASA.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Long_Term_Lasa_Supergenerics_Share_Price_Target_FY27_to_FY28\"><\/span><strong>Long Term Lasa Supergenerics Share Price Target: FY27 to FY28<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>For investors with a 2 to 3 year horizon, the long-term <strong>Lasa Supergenerics share price target<\/strong> is Rs 10.3 in the bull case, assuming full earnings delivery and sector re-rating among peers in pharma intermediates sector.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Bull_Case_and_Bear_Case_for_the_Lasa_Supergenerics_Share_Price_Target\"><\/span><strong>Bull Case and Bear Case for the Lasa Supergenerics Share Price Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Bull_Case_Lasa_Supergenerics_Share_Price_Target_Rs_103\"><\/span><strong>Bull Case Lasa Supergenerics Share Price Target: Rs 10.3<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The bull case of Rs 10.3 materialises when FY27 earnings beat analyst estimates, Pharmaceutical Intermediates and Veterinary APIs tailwinds accelerate, and FII flows return strongly, enabling re-rating toward higher peer multiples in 2026 and beyond.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Bear_Case_Lasa_Supergenerics_Share_Price_Target_Rs_570\"><\/span><strong>Bear Case Lasa Supergenerics Share Price Target: Rs 5.70<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The bear case of Rs 5.70 materialises if FY27 earnings disappoint and FII outflows persist, with the stock approaching the 52 week low support of Rs 5.00.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Scenario<\/th>\n<th>Target<\/th>\n<th>Key Conditions<\/th>\n<\/tr>\n<tr>\n<td>Bull Case<\/td>\n<td>Rs 10.3<\/td>\n<td>FY27 earnings beat, re-rating, FII inflows<\/td>\n<\/tr>\n<tr>\n<td>Base Case<\/td>\n<td>Rs 8.56<\/td>\n<td>In-line FY27 delivery, partial FII recovery<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Rs 5.70<\/td>\n<td>FY27 miss, guidance cut, FII outflows<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_the_Lasa_Supergenerics_Share_Price_Target_2026\"><\/span><strong>Key Risks to the Lasa Supergenerics Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Global_Macro_and_Tariff_Risk\"><\/span><strong>Global Macro and Tariff Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Global tariff tensions and macro headwinds remain a key risk to the <strong>Lasa Supergenerics share price target 2026<\/strong> of Rs 8.56, with FII outflows a direct consequence of sustained geopolitical uncertainty.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Valuation_and_Earnings_Miss_Risk\"><\/span><strong>Valuation and Earnings Miss Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Any FY27 earnings miss or guidance cut could compress multiples, posing the most direct risk to the <strong>Lasa Supergenerics share price target<\/strong> of Rs 8.56.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Competitive_Pressure_in_Pharmaceutical_Intermediates_and_Veterinary_APIs\"><\/span><strong>Competitive Pressure in Pharmaceutical Intermediates and Veterinary APIs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Intensifying competition among peers in pharma intermediates sector could compress Lasa Supergenerics&#8217;s pricing power, a structural risk that must be factored into any assessment of the <strong>Lasa Supergenerics share price target<\/strong> of Rs 8.56.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"FII_Selling_and_Liquidity_Risk\"><\/span><strong>FII Selling and Liquidity Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Sustained FII outflows from Indian equities can delay re-rating toward the <strong>Lasa Supergenerics share price target<\/strong> of Rs 8.56 regardless of company-level improvement through FY27.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Invest_in_Lasa_Supergenerics\"><\/span><strong>How to Invest in Lasa Supergenerics<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data<\/strong><\/a><\/p>\n<p>Begin by reviewing Lasa Supergenerics&#8217;s Q4 FY26 results, annual report, and FY27 guidance released in 2026 before forming a view on the <strong>Lasa Supergenerics share price target<\/strong> of Rs 8.56. Focus on revenue growth, margin trends, and management commentary on Pharmaceutical Intermediates and Veterinary APIs sector opportunities.<\/p>\n<p>Open a Demat and trading account with a SEBI registered stockbroker to buy Lasa Supergenerics (NSE: LASA) with full regulatory protection. Understand the competitive dynamics among peers in pharma intermediates sector before executing any position.<\/p>\n<p>Plan your entry near the 52 week low support of Rs 5.00. A confirmed FY27 earnings uptick would strengthen the entry case for the <strong>Lasa Supergenerics share price target<\/strong> of Rs 8.56. Set a disciplined stop loss below the 52 week low.<\/p>\n<p>Restrict any single stock to 3 to 5 percent of your total equity portfolio to manage concentration risk, especially in the Pharmaceutical Intermediates and Veterinary APIs space where sectoral cycles can amplify volatility.<\/p>\n<p>Always consult a SEBI registered financial advisor before investing based on any <strong>Lasa Supergenerics share price target<\/strong> estimate. SEBI Registration No. INH000013776.<\/p>\n<p><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or the <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Lasa Supergenerics&#8217;s live price and get daily stock recommendations.<\/em><\/p>\n<div style=\"background: #C0392B; padding: 20px 24px; border-radius: 4px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 15px; font-weight: bold; margin: 0; line-height: 1.7;\"><strong>Disclaimer Note:<\/strong> The securities quoted, if any, are for illustration only and are not recommendatory. This content is for educational purposes only and does not constitute investment advice. Investments in securities are subject to market risk. Read all related documents carefully before investing. SEBI Registration No. INH000013776.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Lasa_Supergenerics_Share_Price_Target_2026\"><\/span><strong>FAQs on Lasa Supergenerics Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Lasa_Supergenerics_share_price_target_for_2026\"><\/span><strong>What is the Lasa Supergenerics share price target for 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Lasa Supergenerics share price target 2026 is Rs 8.56, implying approximately 20 percent upside from CMP Rs 7.13. Bull case is Rs 10.3 and bear case is Rs 5.70.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Lasa_Supergenerics_share_price_target_for_2025\"><\/span><strong>What is the Lasa Supergenerics share price target for 2025?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Lasa Supergenerics share price target for 2025 was based on FY26 earnings projections. The current 2026 analyst target is Rs 8.56, reflecting FY27 growth potential from CMP Rs 7.13.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Lasa_Supergenerics_a_good_buy_at_Rs_713\"><\/span><strong>Is Lasa Supergenerics a good buy at Rs 7.13?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> At Rs 7.13, Lasa Supergenerics offers potential upside to the share price target of Rs 8.56 if FY27 earnings recover as projected. Consult a SEBI registered financial advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_52_week_high_and_low_of_Lasa_Supergenerics\"><\/span><strong>What is the 52 week high and low of Lasa Supergenerics?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The 52 week high of Lasa Supergenerics is Rs 14 and the 52 week low is Rs 5.00. At CMP Rs 7.13, the stock offers upside potential toward the 12-month share price target of Rs 8.56.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_to_the_Lasa_Supergenerics_share_price_target\"><\/span><strong>What are the key risks to the Lasa Supergenerics share price target?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Key risks include FY27 earnings miss, US tariff-driven FII outflows, competitive pressure among peers in pharma intermediates sector, and broader market volatility impacting Indian equities in 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_catalysts_for_the_Lasa_Supergenerics_share_price_target\"><\/span><strong>What are the catalysts for the Lasa Supergenerics share price target?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Primary catalysts include FY27 PAT recovery, Pharmaceutical Intermediates and Veterinary APIs sector tailwinds, RBI rate cut support in 2026, Union Budget 2026-27 policy uplift, and normalisation of FII flows into Indian equities.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Lasa_Supergenerics_compare_to_its_peers\"><\/span><strong>How does Lasa Supergenerics compare to its peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Lasa Supergenerics operates in Pharmaceutical Intermediates and Veterinary APIs alongside peers in pharma intermediates sector. At CMP Rs 7.13 with MCap Rs 71 crore, the company is a potential re-rating candidate toward the share price target of Rs 8.56 on FY27 earnings delivery.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Lasa_Supergenerics_share_price_target_for_2027\"><\/span><strong>What is the Lasa Supergenerics share price target for 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The long-term Lasa Supergenerics share price target for FY27 to FY28 is Rs 10.3 in the bull case, assuming continued earnings growth, sector re-rating, and sustained FII inflows. Consult a SEBI registered financial advisor for personalised guidance.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Lasa Supergenerics share price target 2026 is Rs 8.56, ~20% upside from CMP Rs 7.13. Bull Rs 10.3, bear Rs 5.70. 2026.<\/p>\n","protected":false},"author":35,"featured_media":117250,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-117021","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1781498775:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["82"],"rank_math_title":["Lasa Supergenerics Share Price Target 2026: Rs 8.56 Analyst Forecast"],"rank_math_description":["The Lasa Supergenerics share price target 2026 is Rs 8.56, ~20% upside from CMP Rs 7.13. Bull Rs 10.3, bear Rs 5.70. 2026."],"rank_math_focus_keyword":["Lasa Supergenerics share price target"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["117250"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["17789"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/06\/Lasa-Supergenerics-Share-Price-Target.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/117021","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=117021"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/117021\/revisions"}],"predecessor-version":[{"id":117251,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/117021\/revisions\/117251"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/117250"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=117021"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=117021"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=117021"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}